Suche

Anoro Ellipta (previously Anoro)

umeclidinium bromide;vilanterol trifenatate · R03AL03

Elebrato Ellipta

fluticasone furoate;umeclidinium bromide;vilanterol trifenatate · R03AL08

Incruse Ellipta (previously Incruse)

umeclidinium bromide · R03BB07

Laventair Ellipta (previously Laventair)

umeclidinium bromide;vilanterol · R03AL03

Rolufta Ellipta (previously Rolufta)

umeclidinium bromide · R03BB07

Trelegy Ellipta

fluticasone furoate;umeclidinium bromide;vilanterol trifenatate · R03AL08

Anoro Ellipta (previously Anoro) · 4.5 · Although no formal in vivo drug interaction studies have been performed, inhaled umeclidinium/vilanterol has b

Anoro Ellipta (previously Anoro) · 4.5 · Both umeclidinium and vilanterol are substrates of the P-glycoprotein transporter (P-gp). The effect of the mo

Anoro Ellipta (previously Anoro) · 4.5 · Clinically significant interactions mediated by umeclidinium/vilanterol at clinical doses are considered unlik

Anoro Ellipta (previously Anoro) · 4.5 · Co-administration of umeclidinium/vilanterol with other long-acting muscarinic antagonists, long-acting beta2-

Anoro Ellipta (previously Anoro) · 4.5 · Umeclidinium is a substrate of cytochrome P450 2D6 (CYP2D6). The steady-state pharmacokinetics of umeclidinium

Anoro Ellipta (previously Anoro) · 4.8 · The safety profile of ANORO ELLIPTA is based on safety experience with umeclidinium/vilanterol and the individ